awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26772347-BE8FB99D-A74F-4C83-B5DF-93EE67E612D2
Q26772347-BE8FB99D-A74F-4C83-B5DF-93EE67E612D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26772347-BE8FB99D-A74F-4C83-B5DF-93EE67E612D2
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
P2860
Q26772347-BE8FB99D-A74F-4C83-B5DF-93EE67E612D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26772347-BE8FB99D-A74F-4C83-B5DF-93EE67E612D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
60ee2d6549eae760e0c836408313a72e271c69f5
P2860
KIR/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody-dependent cellular cytotoxicity.